glp-1 diabetes news A wave of new #GLP1 drug options for type 2 #Diabetes and #Obesity was a major focus at #ADA2026. In the latest JAMA Medical podcast, Jennifer Abbasi interviews Rita Kalyani, MD Medical professionals share risks of

Although strict glycemic control has beneficial effects on microvascular complications (retinopathy, nephropathy or neuropathy), it does not seem to reduce the risk of cardiovascular disease, and it is associated with an increased risk of hypoglycemia in patients with DM2.3,6 Until recently, the antihyperglycemic drugs available have improved glycemic control, but without much benefits on cardiovascular and/or renal risk

The peptide therapy online guide covers the landscape of online peptide access, including how to evaluate quality claims

A prospective study of the association between physical activity and risk of prostate cancer defined by clinical features and TMPRSS2:ERG

Defining the NG2-expressing cell of the adult CNS

As a board-certified general surgeon specializing in aesthetic surgery, he brings a level of clinical rigor to peptide therapy that simply cannot be replicated by ordering products from an unverified website